6/13/24 19:58 | 6/11/24 | NEXI | Health | Drug | Pharmaceutical Preparations | Jones Kristi | MD | DO | P,CEO | P | 0 | 0.0100 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
3/31/23 16:56 | 3/30/23 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P | 164 | 0.4103 | 0 | 400 | 11 | 4,102 | D | | | | | | | | | | | | | | |
11/17/22 20:40 | 11/17/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P.m | 96 | 0.4811 | 0 | 200 | 6 | 3,627 | D | | | | | | | | | | | | | | |
6/7/22 18:17 | 6/7/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Verstandig Grant | MD | D | | P.m | 148 | 2.22 | 0 | 67 | 7 | 1,054 | D | | | | | | | | | | | | | | |
6/2/22 19:42 | 6/2/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Verstandig Grant | MD | D | | P.m | 298 | 2.24 | 0 | 133 | 16 | 951 | D | | | | | | | | | | | | | | |
6/2/22 19:41 | 6/2/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P.m | 226 | 2.26 | 0 | 100 | 3 | 3,442 | D | | | | | | | | | | | | | | |
3/30/22 19:57 | 3/29/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Jones Kristi | MD | DO | P,CEO | P | 37 | 3.74 | 0 | 10 | 16 | 73 | D | | | | | | | | | | | | | | |
3/28/22 16:15 | 3/24/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Verstandig Grant | MD | D | | P.m | 750 | 3.94 | 0 | 191 | 27 | 905 | D | | | | | | | | | | | | | | |
3/24/22 16:15 | 3/23/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P | 27 | 2.67 | 0 | 10 | 0 | 3,402 | D | | | | | | | | | | | | | | |
3/23/22 16:15 | 3/22/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P | 72 | 2.41 | 0 | 30 | 1 | 3,392 | D | | | | | | | | | | | | | | |
3/22/22 16:15 | 3/21/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P | 64 | 2.14 | 0 | 30 | 1 | 3,362 | D | | | | | | | | | | | | | | |
3/21/22 16:10 | 3/18/22 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P | 63 | 2.11 | 0 | 30 | 1 | 3,332 | D | | | | | | | | | | | | | | |
2/19/21 16:30 | 2/17/21 | NEXI | Health | Drug | Pharmaceutical Preparations | Jones Kristi | MD | O | COO | P.d | 15 | 17.00 | 0 | 1 | 1 | 63 | D | | | | | | | | | | | | | | |
2/19/21 16:30 | 2/17/21 | NEXI | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | MD | O | EVP of R | P | 100 | 17.00 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |
2/19/21 16:25 | 2/17/21 | NEXI | Health | Drug | Pharmaceutical Preparations | Verstandig Grant | MD | D | | P.d | 2,975 | 17.00 | 0 | 175 | 32 | 715 | D | | | | | | | | | | | | | | |
2/19/21 16:20 | 2/17/21 | NEXI | Health | Drug | Pharmaceutical Preparations | Barer Sol J | MD | D | | P.d | 1,020 | 17.00 | 0 | 60 | 2 | 3,252 | M | | | | | | | | | | | | | | |